Sandbox Reserved 1175: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 5: | Line 5: | ||
You may include any references to papers as in: the use of JSmol in Proteopedia <ref>DOI 10.1002/ijch.201300024</ref> or to the article describing Jmol <ref>PMID:21638687</ref> to the rescue. | You may include any references to papers as in: the use of JSmol in Proteopedia <ref>DOI 10.1002/ijch.201300024</ref> or to the article describing Jmol <ref>PMID:21638687</ref> to the rescue. | ||
==Lysophosphatodic Acid== | |||
== Structure == | == Structure == | ||
===Comparison of S1P and LPA=== | ===Comparison of S1P and LPA=== | ||
| Line 12: | Line 13: | ||
== Relevance == | == Relevance == | ||
===Clinical Testing=== | ===Clinical Testing=== | ||
Revision as of 12:18, 15 March 2016
| This Sandbox is Reserved from Jan 11 through August 12, 2016 for use in the course CH462 Central Metabolism taught by R. Jeremy Johnson at the Butler University, Indianapolis, USA. This reservation includes Sandbox Reserved 1160 through Sandbox Reserved 1184. |
To get started:
More help: Help:Editing |
Human Lysophosphatodic Acid Receptor 1
| ||||||||||||